Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
2.780
-0.560 (-16.77%)
Aug 21, 2025, 4:00 PM - Market closed
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $72.32 million as of August 21, 2025. Its market cap has decreased by -17.93% in one year.
Market Cap
72.32M
Enterprise Value
92.24M
1-Year Change
-17.93%
Ranking
Category
Stock Price
$2.78
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $72.32M, a decrease of -79.10%. That is a compound annual growth rate of -30.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 86.89M | 8.48% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 635.59B |
| Johnson & Johnson | 425.72B |
| AbbVie | 366.07B |
| UnitedHealth Group | 279.84B |
| AstraZeneca | 246.07B |
| Novo Nordisk | 241.43B |
| Novartis AG | 240.40B |
| Abbott Laboratories | 224.35B |